Home
LiteratureArticle Details
PMID: 71449
Published · ppublish
English
Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Death from acute pancreatitis. M.R.C. multicentre trial of glucagon and aprotinin.
Abstract
The influence of glucagon and aprotinin ('Trasylol') on the death-rate of acute pancreatitis has been studied in a randomised double-blind multicentre trial. The death-rate in 257 patients was 11%. In the doses used neither drug was found to diminish the risk of death.
MeSH Terms
Acute Disease
Adult
Age Factors
Aged
Aprotinin/administration & dosage,therapeutic use
Clinical Trials as Topic
Drug Administration Schedule
Drug Evaluation
Drug Therapy, Combination
Female
Glucagon/administration & dosage,therapeutic use
Humans
Infusions, Parenteral
Male
Middle Aged
Pancreatitis/drug therapy,etiology,mortality
Placebos
Sex Ratio
Chemicals
Placebos
Glucagon
Aprotinin
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1977-09-24
Pages
632-5
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
